Dopamine agonists such as pramipexole, ropinirole, rotigotine, and apomorphine have long been recommended as initial therapy for younger patients with Parkinson’s disease, typically those younger than ...
For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms but do not truly repair the brain. That assumption is now under direct ...
Throughout 2021 and 2022, researchers at Ghent University Hospital in Belgium watched with cautious optimism as nearly 50 people with early stage Parkinson’s disease visited the clinic as part of a ...
Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman emerged with vastly improved symptoms of the Parkinson's disease that had ...
Neurologists participating in the survey also reported growing dissatisfaction with available treatment options as Parkinson's disease progresses. Physicians estimated that approximately 45% of their ...